ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Is testosterone involved in low female sexual desire?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 154678" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">The main results of this review can be summarized as follows (11): </span></strong></p><p></p><p></p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>The relative hyperandrogenic status of menopause is associated with lower sex hormone binding globulin (SHBG) levels, resulting in increased free testosterone levels; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>Surgical menopause induced by bilateral oophorectomy, however, is associated with a different pattern: significantly lower total and free testosterone levels and dehydroepiandrosterone sulfate (DHEAS) decreased as compared with age-matched controls with both ovaries; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>In the presence of a proper HSDD diagnosis, once informed consent is obtained from the patient, an individualized trial of testosterone therapy for 3 to 6 months could be suggested, aiming midnormal premenopausal testosterone levels during treatment; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>In the absence of clear improvement and if adverse events are observed at 6 months, the use of testosterone should be ceased. There are no safety and efficacy evidences for testosterone therapy in women with HSDD beyond 24 months; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>Ideally, testosterone measurements should be obtained in the morning hours and in the follicular phase of the menstrual cycle. In normally cycling premenopausal women, testosterone levels should be measured at baseline and 3-6 weeks after starting treatment, especially to avoid supraphysiological concentrations, since response to therapy does not correlate with testosterone levels; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>Considering side effects and long-term safety, the role of testosterone in breast cancer and cardiovascular disease pathophysiology requires further elucidation; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>The abuse of androgens in sports and in the community, for aesthetic purposes, remains a major concern. Female athletes reported increased aggressiveness. Dyslipidemia, hypertension, arrhythmia, coagulation disorders, fibrosis, and cardiac hypertrophy have also been observed; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>There are currently no testosterone formulations approved for women by regulatory agencies in the United States, Brazil and most countries. Testosterone formulations approved for men are not recommended for women; </p><p></p><p><span style="color: rgb(184, 49, 47)">*</span>When considering testosterone therapy, all risks and benefits should be thoroughly discussed with the patient before prescription.</p><p></p><p><span style="color: rgb(184, 49, 47)">This position statement was very well developed and leaves no doubt that female sexual dysfunction is a common complaint, specially in postmenopausal women, and may have a negative impact on quality of life.</span> <span style="color: rgb(44, 130, 201)">Testosterone seems to exert a positive effect on sexual desire in women with HSDD, however, requires caution and criteria in its management. </span></p><p></p><p><span style="color: rgb(26, 188, 156)">In addition to the above explained, there is a warning about cases of sexual problems in which testosterone therapy definitely does not work; for instance, when libido is impaired by the partner’s lack of attraction, resentment, anger, fear, embarrassment, or even by myths, taboos, misconceptions about sexual activity. In these cases, non-pharmacological methods are the therapeutic alternatives. </span></p></blockquote><p></p>
[QUOTE="madman, post: 154678, member: 13851"] [B][COLOR=rgb(184, 49, 47)]The main results of this review can be summarized as follows (11): [/COLOR][/B] [COLOR=rgb(184, 49, 47)]*[/COLOR]The relative hyperandrogenic status of menopause is associated with lower sex hormone binding globulin (SHBG) levels, resulting in increased free testosterone levels; [COLOR=rgb(184, 49, 47)]*[/COLOR]Surgical menopause induced by bilateral oophorectomy, however, is associated with a different pattern: significantly lower total and free testosterone levels and dehydroepiandrosterone sulfate (DHEAS) decreased as compared with age-matched controls with both ovaries; [COLOR=rgb(184, 49, 47)]*[/COLOR]In the presence of a proper HSDD diagnosis, once informed consent is obtained from the patient, an individualized trial of testosterone therapy for 3 to 6 months could be suggested, aiming midnormal premenopausal testosterone levels during treatment; [COLOR=rgb(184, 49, 47)]*[/COLOR]In the absence of clear improvement and if adverse events are observed at 6 months, the use of testosterone should be ceased. There are no safety and efficacy evidences for testosterone therapy in women with HSDD beyond 24 months; [COLOR=rgb(184, 49, 47)]*[/COLOR]Ideally, testosterone measurements should be obtained in the morning hours and in the follicular phase of the menstrual cycle. In normally cycling premenopausal women, testosterone levels should be measured at baseline and 3-6 weeks after starting treatment, especially to avoid supraphysiological concentrations, since response to therapy does not correlate with testosterone levels; [COLOR=rgb(184, 49, 47)]*[/COLOR]Considering side effects and long-term safety, the role of testosterone in breast cancer and cardiovascular disease pathophysiology requires further elucidation; [COLOR=rgb(184, 49, 47)]*[/COLOR]The abuse of androgens in sports and in the community, for aesthetic purposes, remains a major concern. Female athletes reported increased aggressiveness. Dyslipidemia, hypertension, arrhythmia, coagulation disorders, fibrosis, and cardiac hypertrophy have also been observed; [COLOR=rgb(184, 49, 47)]*[/COLOR]There are currently no testosterone formulations approved for women by regulatory agencies in the United States, Brazil and most countries. Testosterone formulations approved for men are not recommended for women; [COLOR=rgb(184, 49, 47)]*[/COLOR]When considering testosterone therapy, all risks and benefits should be thoroughly discussed with the patient before prescription. [COLOR=rgb(184, 49, 47)]This position statement was very well developed and leaves no doubt that female sexual dysfunction is a common complaint, specially in postmenopausal women, and may have a negative impact on quality of life.[/COLOR] [COLOR=rgb(44, 130, 201)]Testosterone seems to exert a positive effect on sexual desire in women with HSDD, however, requires caution and criteria in its management. [/COLOR] [COLOR=rgb(26, 188, 156)]In addition to the above explained, there is a warning about cases of sexual problems in which testosterone therapy definitely does not work; for instance, when libido is impaired by the partner’s lack of attraction, resentment, anger, fear, embarrassment, or even by myths, taboos, misconceptions about sexual activity. In these cases, non-pharmacological methods are the therapeutic alternatives. [/COLOR] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Is testosterone involved in low female sexual desire?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top